Oppenheimer & Co’s iShares MSCI Indonesia ETF EIDO Stock Holding History

Oppenheimer & Co’s Portfolio EIDO Stock Details EIDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-56,156	Closed	-$1.26M	–	1391
2022 Q2	$1.26M	Buy	+56,156	New	+$1.35M	0.03%	603

Other funds holding EIDO

State of Tennessee, Department of Treasury Nashville, Tennessee $29.8B AUM 29.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FFM

Fullerton Fund Management Singapore $1.25B AUM 76.88% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Lumbard & Kellner Hollis, New Hampshire $289M AUM 59.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Oppenheimer & Co's EIDO Position: Q3 2022 in Review

Oppenheimer & Co sold out of iShares MSCI Indonesia ETF (EIDO) in Q3 2022, closing a stake of 56,156 shares — an estimated $1.26M sold.

Oppenheimer & Co first reported a position in EIDO in Q2 2022 and held it in 1 quarter. The position peaked at $1.26M in Q2 2022. 93 funds tracked by Wall St. Rank hold EIDO as of Q3 2022.

Oppenheimer & Co reported no remaining iShares MSCI Indonesia ETF position as of Q3 2022 after selling out during the quarter.
Oppenheimer & Co sold 56,156 iShares MSCI Indonesia ETF shares in Q3 2022, an estimated $1.26M.
Oppenheimer & Co first reported a position in iShares MSCI Indonesia ETF in Q2 2022 and held it in 1 quarter.
Oppenheimer & Co's iShares MSCI Indonesia ETF position peaked at $1.26M in Q2 2022.
93 funds tracked by Wall St. Rank held iShares MSCI Indonesia ETF as of Q3 2022.

Based on Oppenheimer & Co's 13F filing for Q3 2022, filed 14 Nov 2022.